Sale!

ASCL1 Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ASCL1 Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the ASCL1 gene responsible for congenital central hypoventilation syndrome (CCHS). This rare genetic disorder affects the autonomic nervous system’s control of breathing, particularly during sleep. Using next-generation sequencing technology, this test provides comprehensive analysis of the ASCL1 gene to detect pathogenic variants that cause life-threatening breathing abnormalities. The test is crucial for infants and children presenting with unexplained breathing difficulties, especially during sleep, and helps guide appropriate medical management and family planning decisions. At just $500 USD, this advanced genetic testing offers critical insights for affected families and healthcare providers managing this complex condition.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ASCL1 Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test

Understanding Congenital Central Hypoventilation Syndrome

Congenital Central Hypoventilation Syndrome (CCHS) is a rare genetic disorder that affects the autonomic nervous system’s ability to control breathing, particularly during sleep. This life-threatening condition is primarily caused by mutations in the ASCL1 gene, which plays a critical role in the development of neural crest cells and the autonomic nervous system. Our advanced NGS Genetic DNA Test provides comprehensive analysis to identify these genetic abnormalities, offering crucial diagnostic information for affected individuals and their families.

What Does the ASCL1 Gene Test Measure?

This sophisticated genetic test utilizes Next-Generation Sequencing (NGS) technology to thoroughly examine the ASCL1 gene for pathogenic variants. The test specifically detects:

  • Point mutations and small insertions/deletions in the ASCL1 gene
  • Polyalanine repeat expansions that commonly cause CCHS
  • Frameshift mutations affecting protein function
  • Missense and nonsense mutations impacting gene expression
  • Regulatory region variants that may affect gene regulation

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is recommended for individuals presenting with:

  • Unexplained breathing difficulties, especially during sleep
  • Infants with apparent life-threatening events (ALTE)
  • Children requiring mechanical ventilation for unclear reasons
  • Family history of sudden infant death syndrome (SIDS)
  • Associated autonomic nervous system abnormalities
  • Hirschsprung disease with breathing concerns
  • Neural crest tumor history with respiratory symptoms

Comprehensive Benefits of ASCL1 Genetic Testing

Undergoing this genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out CCHS with high precision
  • Family Planning: Enables informed reproductive decisions for at-risk families
  • Early Intervention: Facilitates timely medical management and ventilator support
  • Prognostic Information: Helps predict disease severity and progression
  • Genetic Counseling: Provides basis for comprehensive family risk assessment
  • Treatment Guidance: Informs appropriate respiratory care strategies

Understanding Your Test Results

Interpretation Guidelines

Our genetic specialists provide detailed interpretation of your results:

  • Positive Result: Indicates presence of pathogenic ASCL1 mutation confirming CCHS diagnosis
  • Negative Result: Suggests absence of detectable ASCL1 mutations but doesn’t completely rule out CCHS
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Identifies individuals with single mutation copy who may pass condition to offspring

Test Specifications and Pricing

Test Parameter Details
Test Name ASCL1 Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS)
Specialty Pediatrics
Department Genetics

Pre-Test Requirements and Genetic Counseling

Before testing, we recommend:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree
  • Discussion of potential implications for family members
  • Understanding of test limitations and possible outcomes
  • Informed consent process explaining benefits and risks

Nationwide Accessibility

We have diagnostic centers conveniently located across major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services for families nationwide.

Take Action Today

Don’t wait to get the answers you need for proper diagnosis and management of congenital central hypoventilation syndrome. Our expert genetic counselors and medical professionals are ready to assist you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the ASCL1 Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test. Early diagnosis can make a significant difference in managing this complex condition effectively.